Literature DB >> 26408530

Data Normalization Strategies for MicroRNA Quantification.

Heidi Schwarzenbach1, Andreia Machado da Silva2, George Calin3, Klaus Pantel4.   

Abstract

BACKGROUND: Different technologies, such as quantitative real-time PCR or microarrays, have been developed to measure microRNA (miRNA) expression levels. Quantification of miRNA transcripts implicates data normalization using endogenous and exogenous reference genes for data correction. However, there is no consensus about an optimal normalization strategy. The choice of a reference gene remains problematic and can have a serious impact on the actual available transcript levels and, consequently, on the biological interpretation of data. CONTENT: In this review article we discuss the reliability of the use of small RNAs, commonly reported in the literature as miRNA expression normalizers, and compare different strategies used for data normalization.
SUMMARY: A workflow strategy is proposed for normalization of miRNA expression data in an attempt to provide a basis for the establishment of a global standard procedure that will allow comparison across studies.
© 2015 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408530      PMCID: PMC4890630          DOI: 10.1373/clinchem.2015.239459

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  89 in total

1.  mRNA and microRNA quality control for RT-qPCR analysis.

Authors:  C Becker; A Hammerle-Fickinger; I Riedmaier; M W Pfaffl
Journal:  Methods       Date:  2010-01-15       Impact factor: 3.608

2.  Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?

Authors:  Meike Spiekermann; Klaus-Peter Dieckmann; Thomas Balks; Jörn Bullerdiek; Gazanfer Belge
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

3.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

4.  Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.

Authors:  Kristin R Delfino; Sandra L Rodriguez-Zas
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

5.  Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma.

Authors:  Gusheng Tang; Xiaojun Shen; Kaiyang Lv; Yu Wu; Jianwei Bi; Qian Shen
Journal:  Med Sci Monit       Date:  2015-02-26

6.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.

Authors:  Kenneth W Witwer; Edit I Buzás; Lynne T Bemis; Adriana Bora; Cecilia Lässer; Jan Lötvall; Esther N Nolte-'t Hoen; Melissa G Piper; Sarada Sivaraman; Johan Skog; Clotilde Théry; Marca H Wauben; Fred Hochberg
Journal:  J Extracell Vesicles       Date:  2013-05-27

7.  U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.

Authors:  Fabian Benz; Christoph Roderburg; David Vargas Cardenas; Mihael Vucur; Jérémie Gautheron; Alexander Koch; Henning Zimmermann; Jörn Janssen; Lukas Nieuwenhuijsen; Mark Luedde; Norbert Frey; Frank Tacke; Christian Trautwein; Tom Luedde
Journal:  Exp Mol Med       Date:  2013-09-20       Impact factor: 8.718

8.  Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma.

Authors:  Yi Li; Liqun Zhang; Fei Liu; Guiming Xiang; Dongneng Jiang; Xiaoyun Pu
Journal:  Dis Markers       Date:  2015-02-26       Impact factor: 3.434

9.  Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma.

Authors:  Vasily N Aushev; Irina B Zborovskaya; Konstantin K Laktionov; Nicolas Girard; Marie-Pierre Cros; Zdenko Herceg; Vladimir Krutovskikh
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  A critical evaluation of microRNA biomarkers in non-neoplastic disease.

Authors:  Baqer A Haider; Alexander S Baras; Matthew N McCall; Joshua A Hertel; Toby C Cornish; Marc K Halushka
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more
  176 in total

Review 1.  The choice of endogenous controls in exosomal microRNA assessments from biofluids.

Authors:  G Occhipinti; M Giulietti; G Principato; F Piva
Journal:  Tumour Biol       Date:  2016-07-20

2.  Circulating miRNA 887 is differentially expressed in ARDS and modulates endothelial function.

Authors:  Andrew J Goodwin; Pengfei Li; Perry V Halushka; James A Cook; Aman S Sumal; Hongkuan Fan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-22       Impact factor: 5.464

Review 3.  Unraveling the Role of MicroRNAs in Mycobacterium tuberculosis Infection and Disease: Advances and Pitfalls.

Authors:  Cinthya Ruiz-Tagle; Rodrigo Naves; María Elvira Balcells
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

4.  Identification of endogenous microRNA references in porcine serum for quantitative real-time PCR normalization.

Authors:  In-Seon Bae; Kang-Seok Seo; Sang Hoon Kim
Journal:  Mol Biol Rep       Date:  2018-07-25       Impact factor: 2.316

5.  Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.

Authors:  Chung Wah Wu; Xiaoming Cao; Calise K Berger; Patrick H Foote; Douglas W Mahoney; Julie A Simonson; Bradley W Anderson; Tracy C Yab; William R Taylor; Lisa A Boardman; John B Kisiel; David A Ahlquist
Journal:  Dig Dis Sci       Date:  2017-06-28       Impact factor: 3.199

6.  Comparison of exosomal microRNAs secreted by 786-O clear cell renal carcinoma cells and HK-2 proximal tubule-derived cells in culture identifies microRNA-205 as a potential biomarker of clear cell renal carcinoma.

Authors:  Victor C Crentsil; Hui Liu; Donald F Sellitti
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

Review 7.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

8.  Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease.

Authors:  Louise Benning; Samuel Robinson; Marie Follo; Lukas Andreas Heger; Daniela Stallmann; Daniel Duerschmied; Christoph Bode; Ingo Ahrens; Marcus Hortmann
Journal:  J Vis Exp       Date:  2018-07-03       Impact factor: 1.355

9.  Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus.

Authors:  Carmen Pheiffer; Stephanie Dias; Paul Rheeder; Sumaiya Adam
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

Review 10.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.